FDA Inspection 863237 — Biologic Therapy Core Facility, Siteman Cancer Center

Biologic Therapy Core Facility, Siteman Cancer Center — FEI 3007743644

The FDA completed an inspection of Biologic Therapy Core Facility, Siteman Cancer Center on Jan 14, 2014 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 14, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Saint Louis, MO (United States)